Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection

NCT02765490 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

365

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: AL-335
DRUG: Odalasvir
DRUG: Simeprevir

Sponsor

Janssen Research & Development, LLC